PrediXcan has been applied to bipolar disorder, resulting in the identification of two genes, PTPRE and BBX, for which predicted increased expression in whole blood and the anterior cingulate cortex, respectively, was associated with increased risk of bipolar disorder (Shah et al.2016). This evidence concerns the gene PTPRE and bipolar disorder.